nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.201	0.313	CbGbCtD
Montelukast—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0991	0.154	CbGbCtD
Montelukast—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0723	0.112	CbGbCtD
Montelukast—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0691	0.107	CbGbCtD
Montelukast—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0432	0.0672	CbGbCtD
Montelukast—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0417	0.0648	CbGbCtD
Montelukast—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0402	0.0625	CbGbCtD
Montelukast—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0296	0.046	CbGbCtD
Montelukast—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0185	0.0287	CbGbCtD
Montelukast—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0169	0.0263	CbGbCtD
Montelukast—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0115	0.0179	CbGbCtD
Montelukast—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.000973	CcSEcCtD
Montelukast—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000347	0.000972	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000346	0.00097	CcSEcCtD
Montelukast—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000344	0.000964	CcSEcCtD
Montelukast—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000344	0.000964	CcSEcCtD
Montelukast—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000344	0.000963	CcSEcCtD
Montelukast—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000341	0.000956	CcSEcCtD
Montelukast—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.000954	CcSEcCtD
Montelukast—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.000953	CcSEcCtD
Montelukast—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.000945	CcSEcCtD
Montelukast—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000336	0.000942	CcSEcCtD
Montelukast—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000336	0.000942	CcSEcCtD
Montelukast—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000336	0.000941	CcSEcCtD
Montelukast—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000336	0.000941	CcSEcCtD
Montelukast—Infection—Cisplatin—peripheral nervous system neoplasm	0.000334	0.000935	CcSEcCtD
Montelukast—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000333	0.000934	CcSEcCtD
Montelukast—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000331	0.000927	CcSEcCtD
Montelukast—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000331	0.000927	CcSEcCtD
Montelukast—Rash—Topotecan—peripheral nervous system neoplasm	0.000331	0.000927	CcSEcCtD
Montelukast—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00033	0.000926	CcSEcCtD
Montelukast—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000329	0.000923	CcSEcCtD
Montelukast—Cough—Etoposide—peripheral nervous system neoplasm	0.000329	0.000922	CcSEcCtD
Montelukast—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000329	0.000922	CcSEcCtD
Montelukast—Headache—Topotecan—peripheral nervous system neoplasm	0.000329	0.000921	CcSEcCtD
Montelukast—Rash—Tretinoin—peripheral nervous system neoplasm	0.000328	0.000919	CcSEcCtD
Montelukast—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000328	0.000919	CcSEcCtD
Montelukast—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000328	0.000919	CcSEcCtD
Montelukast—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000328	0.000918	CcSEcCtD
Montelukast—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000328	0.000918	CcSEcCtD
Montelukast—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000328	0.000918	CcSEcCtD
Montelukast—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000327	0.000916	CcSEcCtD
Montelukast—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000327	0.000915	CcSEcCtD
Montelukast—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000326	0.000914	CcSEcCtD
Montelukast—Headache—Tretinoin—peripheral nervous system neoplasm	0.000326	0.000913	CcSEcCtD
Montelukast—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000326	0.000913	CcSEcCtD
Montelukast—Pain—Vincristine—peripheral nervous system neoplasm	0.000325	0.000911	CcSEcCtD
Montelukast—Rash—Melphalan—peripheral nervous system neoplasm	0.000324	0.000907	CcSEcCtD
Montelukast—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000324	0.000907	CcSEcCtD
Montelukast—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000322	0.000904	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000319	0.000894	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000886	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000886	CcSEcCtD
Montelukast—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000314	0.00088	CcSEcCtD
Montelukast—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000313	0.000878	CcSEcCtD
Montelukast—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.000878	CcSEcCtD
Montelukast—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.000873	CcSEcCtD
Montelukast—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.000873	CcSEcCtD
Montelukast—Nausea—Topotecan—peripheral nervous system neoplasm	0.000312	0.000873	CcSEcCtD
Montelukast—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000311	0.000871	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000868	CcSEcCtD
Montelukast—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000309	0.000866	CcSEcCtD
Montelukast—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000309	0.000866	CcSEcCtD
Montelukast—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000308	0.000863	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000306	0.000858	CcSEcCtD
Montelukast—Infection—Etoposide—peripheral nervous system neoplasm	0.000306	0.000857	CcSEcCtD
Montelukast—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000305	0.000855	CcSEcCtD
Montelukast—Nausea—Melphalan—peripheral nervous system neoplasm	0.000305	0.000855	CcSEcCtD
Montelukast—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000303	0.00085	CcSEcCtD
Montelukast—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000303	0.00085	CcSEcCtD
Montelukast—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000302	0.000845	CcSEcCtD
Montelukast—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000301	0.000844	CcSEcCtD
Montelukast—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000842	CcSEcCtD
Montelukast—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.0003	0.000842	CcSEcCtD
Montelukast—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.0003	0.000842	CcSEcCtD
Montelukast—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000299	0.000838	CcSEcCtD
Montelukast—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000834	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.00082	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.00082	CcSEcCtD
Montelukast—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000818	CcSEcCtD
Montelukast—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000291	0.000815	CcSEcCtD
Montelukast—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.000814	CcSEcCtD
Montelukast—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000814	CcSEcCtD
Montelukast—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00029	0.000813	CcSEcCtD
Montelukast—Pain—Cisplatin—peripheral nervous system neoplasm	0.000287	0.000805	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000803	CcSEcCtD
Montelukast—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.000793	CcSEcCtD
Montelukast—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000282	0.00079	CcSEcCtD
Montelukast—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000787	CcSEcCtD
Montelukast—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000787	CcSEcCtD
Montelukast—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00028	0.000784	CcSEcCtD
Montelukast—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.000782	CcSEcCtD
Montelukast—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000779	CcSEcCtD
Montelukast—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000276	0.000774	CcSEcCtD
Montelukast—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000771	CcSEcCtD
Montelukast—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000274	0.000767	CcSEcCtD
Montelukast—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000273	0.000764	CcSEcCtD
Montelukast—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000762	CcSEcCtD
Montelukast—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000758	CcSEcCtD
Montelukast—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000758	CcSEcCtD
Montelukast—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000758	CcSEcCtD
Montelukast—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00027	0.000758	CcSEcCtD
Montelukast—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000757	CcSEcCtD
Montelukast—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.000756	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000752	CcSEcCtD
Montelukast—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000268	0.000751	CcSEcCtD
Montelukast—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000266	0.000745	CcSEcCtD
Montelukast—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000266	0.000744	CcSEcCtD
Montelukast—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000265	0.000744	CcSEcCtD
Montelukast—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000743	CcSEcCtD
Montelukast—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000739	CcSEcCtD
Montelukast—Pain—Etoposide—peripheral nervous system neoplasm	0.000263	0.000738	CcSEcCtD
Montelukast—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000737	CcSEcCtD
Montelukast—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000731	CcSEcCtD
Montelukast—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.000731	CcSEcCtD
Montelukast—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00026	0.000729	CcSEcCtD
Montelukast—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000717	CcSEcCtD
Montelukast—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000715	CcSEcCtD
Montelukast—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000711	CcSEcCtD
Montelukast—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000253	0.000708	CcSEcCtD
Montelukast—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000705	CcSEcCtD
Montelukast—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000252	0.000705	CcSEcCtD
Montelukast—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000251	0.000704	CcSEcCtD
Montelukast—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.000703	CcSEcCtD
Montelukast—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000701	CcSEcCtD
Montelukast—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000701	CcSEcCtD
Montelukast—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000701	CcSEcCtD
Montelukast—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.000697	CcSEcCtD
Montelukast—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000248	0.000696	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000695	CcSEcCtD
Montelukast—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000248	0.000694	CcSEcCtD
Montelukast—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.000692	CcSEcCtD
Montelukast—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000688	CcSEcCtD
Montelukast—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000245	0.000685	CcSEcCtD
Montelukast—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000684	CcSEcCtD
Montelukast—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000682	CcSEcCtD
Montelukast—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000243	0.000682	CcSEcCtD
Montelukast—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000243	0.000682	CcSEcCtD
Montelukast—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000682	CcSEcCtD
Montelukast—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000681	CcSEcCtD
Montelukast—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000677	CcSEcCtD
Montelukast—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000242	0.000677	CcSEcCtD
Montelukast—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000241	0.000675	CcSEcCtD
Montelukast—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000675	CcSEcCtD
Montelukast—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000672	CcSEcCtD
Montelukast—Rash—Vincristine—peripheral nervous system neoplasm	0.00024	0.000671	CcSEcCtD
Montelukast—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000239	0.000671	CcSEcCtD
Montelukast—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000669	CcSEcCtD
Montelukast—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000667	CcSEcCtD
Montelukast—Headache—Vincristine—peripheral nervous system neoplasm	0.000238	0.000667	CcSEcCtD
Montelukast—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000663	CcSEcCtD
Montelukast—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000662	CcSEcCtD
Montelukast—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000658	CcSEcCtD
Montelukast—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000234	0.000656	CcSEcCtD
Montelukast—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00023	0.000644	CcSEcCtD
Montelukast—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000643	CcSEcCtD
Montelukast—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000227	0.000635	CcSEcCtD
Montelukast—Nausea—Vincristine—peripheral nervous system neoplasm	0.000226	0.000632	CcSEcCtD
Montelukast—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000632	CcSEcCtD
Montelukast—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000631	CcSEcCtD
Montelukast—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00063	CcSEcCtD
Montelukast—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000627	CcSEcCtD
Montelukast—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000625	CcSEcCtD
Montelukast—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000622	CcSEcCtD
Montelukast—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000221	0.000619	CcSEcCtD
Montelukast—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000619	CcSEcCtD
Montelukast—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000617	CcSEcCtD
Montelukast—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000615	CcSEcCtD
Montelukast—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000613	CcSEcCtD
Montelukast—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000218	0.00061	CcSEcCtD
Montelukast—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000214	0.000599	CcSEcCtD
Montelukast—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000596	CcSEcCtD
Montelukast—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000595	CcSEcCtD
Montelukast—Rash—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000594	CcSEcCtD
Montelukast—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000593	CcSEcCtD
Montelukast—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000211	0.00059	CcSEcCtD
Montelukast—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000584	CcSEcCtD
Montelukast—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000204	0.00057	CcSEcCtD
Montelukast—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00057	CcSEcCtD
Montelukast—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000569	CcSEcCtD
Montelukast—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000567	CcSEcCtD
Montelukast—Nausea—Cisplatin—peripheral nervous system neoplasm	0.0002	0.000559	CcSEcCtD
Montelukast—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000552	CcSEcCtD
Montelukast—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000196	0.000548	CcSEcCtD
Montelukast—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000544	CcSEcCtD
Montelukast—Rash—Etoposide—peripheral nervous system neoplasm	0.000194	0.000544	CcSEcCtD
Montelukast—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000194	0.000543	CcSEcCtD
Montelukast—Headache—Etoposide—peripheral nervous system neoplasm	0.000193	0.00054	CcSEcCtD
Montelukast—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000527	CcSEcCtD
Montelukast—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000524	CcSEcCtD
Montelukast—Cough—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000517	CcSEcCtD
Montelukast—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000513	CcSEcCtD
Montelukast—Nausea—Etoposide—peripheral nervous system neoplasm	0.000183	0.000512	CcSEcCtD
Montelukast—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000504	CcSEcCtD
Montelukast—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000504	CcSEcCtD
Montelukast—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000504	CcSEcCtD
Montelukast—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000503	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000501	CcSEcCtD
Montelukast—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000484	CcSEcCtD
Montelukast—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000483	CcSEcCtD
Montelukast—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000483	CcSEcCtD
Montelukast—Infection—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00048	CcSEcCtD
Montelukast—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000478	CcSEcCtD
Montelukast—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000475	CcSEcCtD
Montelukast—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000474	CcSEcCtD
Montelukast—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000473	CcSEcCtD
Montelukast—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00047	CcSEcCtD
Montelukast—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000467	CcSEcCtD
Montelukast—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000467	CcSEcCtD
Montelukast—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000465	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000463	CcSEcCtD
Montelukast—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000447	CcSEcCtD
Montelukast—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000447	CcSEcCtD
Montelukast—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000444	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000157	0.00044	CcSEcCtD
Montelukast—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000439	CcSEcCtD
Montelukast—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000438	CcSEcCtD
Montelukast—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000437	CcSEcCtD
Montelukast—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000435	CcSEcCtD
Montelukast—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000434	CcSEcCtD
Montelukast—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00043	CcSEcCtD
Montelukast—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000426	CcSEcCtD
Montelukast—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000417	CcSEcCtD
Montelukast—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000417	CcSEcCtD
Montelukast—Pain—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000413	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000408	CcSEcCtD
Montelukast—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000405	CcSEcCtD
Montelukast—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000402	CcSEcCtD
Montelukast—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000398	CcSEcCtD
Montelukast—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000395	CcSEcCtD
Montelukast—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000394	CcSEcCtD
Montelukast—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000386	CcSEcCtD
Montelukast—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000386	CcSEcCtD
Montelukast—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000384	CcSEcCtD
Montelukast—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000383	CcSEcCtD
Montelukast—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000382	CcSEcCtD
Montelukast—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000382	CcSEcCtD
Montelukast—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000366	CcSEcCtD
Montelukast—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000356	CcSEcCtD
Montelukast—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000355	CcSEcCtD
Montelukast—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000354	CcSEcCtD
Montelukast—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000354	CcSEcCtD
Montelukast—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000347	CcSEcCtD
Montelukast—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000342	CcSEcCtD
Montelukast—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000331	CcSEcCtD
Montelukast—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00033	CcSEcCtD
Montelukast—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000321	CcSEcCtD
Montelukast—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000114	0.00032	CcSEcCtD
Montelukast—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000317	CcSEcCtD
Montelukast—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000307	CcSEcCtD
Montelukast—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000306	CcSEcCtD
Montelukast—Rash—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000305	CcSEcCtD
Montelukast—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000305	CcSEcCtD
Montelukast—Headache—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000303	CcSEcCtD
Montelukast—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000296	CcSEcCtD
Montelukast—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000287	CcSEcCtD
Montelukast—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000284	CcSEcCtD
Montelukast—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000282	CcSEcCtD
Montelukast—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000282	CcSEcCtD
Montelukast—Headache—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00028	CcSEcCtD
Montelukast—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.000266	CcSEcCtD
